China will add 111 drugs to its national medical reimbursement list this year, with a focus on including treatments for infections, COVID-19 drugs and advanced medications for children s diseases and tumors.
Frustration is rising over Covid drug shortages in China, and there are no easy answers kesq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kesq.com Daily Mail and Mail on Sunday newspapers.
China residents scrambling to secure Western medications as a wave of Covid-19 overwhelms the country, driving up demand for treatment especially for the country s large undervaccinated elderly population.
Albert Bourla, CEO of US-based pharmaceutical company Pfizer, reportedly said at a conference on Monday that they had signed agreements with a Chinese enterprise for localized production of the anti-COVID-19 drug Paxlovid.